Redox-sensitive doxorubicin liposome: a formulation approach for targeted tumor therapy

In this study redox-sensitive (RS) liposomes manufactured using 10,10′-diselanediylbis decanoic acid (DDA), an organoselenium RS compound, to enhance the therapeutic performance of doxorubicin (Dox). The DDA structure was confirmed by 1H NMR and LC–MS/MS. Various liposomal formulations (33 formulati...

Descripción completa

Detalles Bibliográficos
Autores principales: Mirhadi, Elaheh, Mashreghi, Mohammad, Askarizadeh, Anis, Mehrabian, Amin, Alavizadeh, Seyedeh Hoda, Arabi, Leila, Badiee, Ali, Jaafari, Mahmoud Reza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253031/
https://www.ncbi.nlm.nih.gov/pubmed/35788647
http://dx.doi.org/10.1038/s41598-022-15239-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253031/
https://www.ncbi.nlm.nih.gov/pubmed/35788647
http://dx.doi.org/10.1038/s41598-022-15239-x

Ejemplares similares